Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate

Author: Benzinga Newsdesk | August 08, 2024 06:13pm
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 75.86 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $3.39 million which missed the analyst consensus estimate of $3.94 million by 13.93 percent. This is a 1.05 percent decrease over sales of $3.43 million the same period last year.

Posted In: SNOA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist